Oncology
Inactivation of CHFR in NPC caused by promoter methylation
Published in Gene Therapy Weekly, October 13th, 2005
"Chromosomal instability (CIN) is a cytogenetic hallmark of human cancers. Increasing evidence suggests that impairment of mitotic checkpoint is causally associated with CIN," scientists writing in the journal Molecular Carcinogenesis report.
"CHFR is one of the mitotic checkpoint regulators and it delays chromosome condensation in response to mitotic stress. Epigenetic inactivation of CHFR through promoter CpG hypermethylation may lead to CIN and has been reported in several human cancers," recount H.W. Cheung and colleagues,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-10-13)
More Articles from Gene Therapy Weekly
- DNA Vaccines
Method to recover plasmid DNA based on aqueous two-phase separation - Gene Therapy
Modified magnetic nanoparticles enhanced gene delivery of HVJ-E vector - Gene Therapy
Suppression of fat deposition for the lifetime with gene therapy - Vaccine Vectors
Signal in spleen necrosis virus does not allow efficient gene transfer - Vector Development
Nonviral vector for gene delivery and expression in brain developed - Alzheimer Disease
Targeting key enzyme with gene therapy reversed Alzheimer disease in mice - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
